2020 ASCO Virtual Direct™ Highlights
Playback speed
10 seconds
2020 ASCO Updates on IDH2-Mutated ND-AML: ENA+AZA vs. AZA Mono - What Are the OS/Remission Effects? Is This Combination Clinically Meaningful?
By
2020 ASCO Virtual Direct™ Highlights
FEATURING
Terrence Bradley
By
2020 ASCO Virtual Direct™ Highlights
FEATURING
Terrence Bradley
108 views
September 29, 2020
Login to view comments.
Click here to Login
Hematologic Oncology